Integrated Wealth Concepts LLC Enveric Biosciences, Inc. Transaction History

Integrated Wealth Concepts LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$8.8 - $16.2 $95,048 - $174,976	-10,801 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$46.5 - $104.0 $1.56 Million - $3.5 Million	-33,640 Reduced 75.7%	10,801 $10,000
Q3 2021 Nov 15, 2021	BUY	$80.5 - $175.0 $3.58 Million - $7.78 Million	44,441 New	44,441 $92,000

Ticker ENVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,078,270
Market Cap $1.04M
Description
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Wealth Concepts LLC with notifications on news.